Zacks: Brokerages Expect Nu Skin Enterprises, Inc. (NUS) to Announce $0.90 Earnings Per Share

Share on StockTwits

Wall Street brokerages expect that Nu Skin Enterprises, Inc. (NYSE:NUS) will announce $0.90 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Nu Skin Enterprises’ earnings. The lowest EPS estimate is $0.85 and the highest is $0.92. Nu Skin Enterprises posted earnings per share of $0.77 during the same quarter last year, which would indicate a positive year over year growth rate of 16.9%. The company is scheduled to announce its next earnings report on Wednesday, November 7th.

According to Zacks, analysts expect that Nu Skin Enterprises will report full year earnings of $3.61 per share for the current year, with EPS estimates ranging from $3.59 to $3.65. For the next financial year, analysts anticipate that the business will report earnings of $4.08 per share, with EPS estimates ranging from $3.76 to $4.54. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that follow Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Thursday, August 2nd. The company reported $1.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.18. The business had revenue of $704.19 million for the quarter, compared to analysts’ expectations of $642.16 million. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.67%. The business’s quarterly revenue was up 28.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.77 earnings per share.

Several brokerages have recently issued reports on NUS. Zacks Investment Research raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $95.00 price target on the stock in a research report on Monday, August 6th. ValuEngine cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 6th. Jefferies Financial Group initiated coverage on shares of Nu Skin Enterprises in a report on Thursday, June 14th. They issued a “buy” rating and a $98.00 target price on the stock. Finally, Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and raised their target price for the company from $57.00 to $70.00 in a report on Thursday, August 2nd. They noted that the move was a valuation call. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Nu Skin Enterprises has an average rating of “Buy” and an average price target of $85.33.

Shares of NUS traded down $1.03 during mid-day trading on Tuesday, hitting $79.42. 288,205 shares of the company’s stock were exchanged, compared to its average volume of 346,951. The stock has a market capitalization of $4.42 billion, a PE ratio of 23.57, a P/E/G ratio of 2.27 and a beta of 1.11. Nu Skin Enterprises has a fifty-two week low of $59.31 and a fifty-two week high of $88.68. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.19 and a current ratio of 1.82.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 12th. Investors of record on Friday, August 31st will be issued a $0.365 dividend. The ex-dividend date is Thursday, August 30th. This represents a $1.46 annualized dividend and a yield of 1.84%. Nu Skin Enterprises’s dividend payout ratio (DPR) is 45.20%.

In related news, General Counsel D Matthew Dorny sold 3,500 shares of the firm’s stock in a transaction that occurred on Monday, July 2nd. The shares were sold at an average price of $77.65, for a total value of $271,775.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Edwina D. Woodbury sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, August 6th. The shares were sold at an average price of $85.02, for a total transaction of $425,100.00. Following the completion of the sale, the director now directly owns 11,860 shares in the company, valued at approximately $1,008,337.20. The disclosure for this sale can be found here. In the last ninety days, insiders sold 43,850 shares of company stock worth $3,589,888. 5.20% of the stock is owned by corporate insiders.

A number of large investors have recently modified their holdings of NUS. Wells Fargo & Company MN increased its stake in Nu Skin Enterprises by 17.9% in the first quarter. Wells Fargo & Company MN now owns 58,634 shares of the company’s stock valued at $4,322,000 after purchasing an additional 8,889 shares during the last quarter. Rhumbline Advisers increased its stake in Nu Skin Enterprises by 7.4% in the first quarter. Rhumbline Advisers now owns 105,504 shares of the company’s stock valued at $7,777,000 after purchasing an additional 7,276 shares during the last quarter. Meeder Asset Management Inc. increased its stake in Nu Skin Enterprises by 27.1% in the first quarter. Meeder Asset Management Inc. now owns 16,305 shares of the company’s stock valued at $1,202,000 after purchasing an additional 3,475 shares during the last quarter. Prudential Financial Inc. increased its stake in Nu Skin Enterprises by 2.6% in the first quarter. Prudential Financial Inc. now owns 427,071 shares of the company’s stock valued at $31,480,000 after purchasing an additional 10,642 shares during the last quarter. Finally, Swiss National Bank increased its stake in Nu Skin Enterprises by 2.1% in the first quarter. Swiss National Bank now owns 92,100 shares of the company’s stock valued at $6,789,000 after purchasing an additional 1,900 shares during the last quarter. 76.11% of the stock is currently owned by hedge funds and other institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

See Also: Penny Stocks, What You Need To Know

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.